STOCKS TELEGRAPH

Tag: RMED stock

  • Ra Medical Systems Inc. (RMED) stock Sinks After Hours on Q4 & Fiscal 2021 Results

    Ra Medical Systems Inc. (RMED) stock Sinks After Hours on Q4 & Fiscal 2021 Results

    On March 23, Ra Medical Systems Inc. (RMED) declared its financial results for the fourth quarter and fiscal year 2021. Consequently, the stock took a hit in the after-hours and plunged down.

    Source: SoFi

    It seems investors were looking forward to the earnings release with positive anticipation. The stock traded in the green during the regular session at an above-average volume of 4.91 million shares. Intraday trading, RMED varied between a high of $0.53 and a low of $0.49. At the close of the session, the stock had a value of $0.51 with a mild gain of 0.02%. Following the results, the stock entered the red with a huge loss of 11.43% in the after-hours. Hence, RMED was trading at a price of $0.45 per share in the after-hours while 1.61 million shares exchanged hands.

    The dermatologic and cardiovascular diseases excimer lasers developer, Ra Medical Systems Inc. was founded in 2002. Currently, the company has a market capitalization of $13.43 million with its 26.33 million outstanding shares.

    RMED’s Q4 2021 Results

    For Q4 2021, the company reported net revenue of $5,000 in product sales while there was no revenue in the year-ago quarter.

    Moreover, RMED had a net operating loss of $8.3 million in Q4 2021 against $10.2 million in the year-ago period. Thus, the net operating loss per share was $1.23 and $3.54 for Q4 2021 and 2020 respectively.

    Fiscal 2021 Results

    From Continuing Operations

    In fiscal 2021, the company generated net revenue of $22,000 in product sales against $0.3 million in the previous year.

    Furthermore, the net operating loss was $27.3 million ($5.39/share) in fiscal 2021 against $35.3 million ($20.79) in fiscal 2020.

    From Discontinued Operations

    The company reported $2.6 million in net revenue from discontinued operations in 2021 against $4.1 million a year ago.

    Additionally, the company had an income of $2.2 million ($0.43/share) in 2021 against a loss of $0.7 million ($0.43/share) in 2020.

    RMED’s 510(k) Filing

    On February 28, RMED filed a 510(k) application with the FDA for its DABRA catheter with a braided over jacket and shelf life of 6 months. The 510(K) was filed for crossing chronic total occlusions in symptomatic infrainguinal lower extremity vascular disease patients with intended use for ablating channels in occlusive peripheral vascular disease.

    Conclusion

    The company’s lasted earnings report failed to impress the investors after its release on Wednesday. Therefore, RMED stock plunged down in the after-hours when the result was declared.

  • Ra Medical Systems Inc. (RMED) stock Falls Under Corrections After Hours

    On February 28, Ra Medical Systems Inc. (RMED) announced to have filed a 510(k) application for its DABRA Catheter with the FDA. Consequently, the stock added 17.02% in the following market session on March 01. The gain called for-profit booking and corrections in the after-hours on Tuesday.

    The news resulted in investors flocking towards the stock on Tuesday as its volume reached 85.47 million. During the regular session, RMED stock was able to add a value of $0.07 or 17.02%. The stock closed the session at a price of $0.50 per share. Subsequently, the stock fell under corrections in the after-hours to lose 4.96%. Hence, the stock was trading at a value of $0.48 per share in the after-hours on Tuesday.

    The dermatologic and cardiovascular diseases excimer lasers developer, Ra Medical Systems Inc. was founded in 2002. The company has a market capitalization of $11.24 million with 26.33 million shares outstanding.

    RMED stock Analysis

    While Tuesday’s regular session gains were enough to call for profit booking, the stock had been in an uptrend for the past few days. Thus, RMED stock was bound to fall under corrections with the extended gains on Tuesday. Therefore, the stock succumbed to corrections in the after-hours as it had added 40.00% in the past five days.

    The uptrend of the stock before the news seemed to have been due to the recent downfall of the stock. With the apparent crash of the stock market due to the Russia-Ukraine conflict, RMED also declined to its new low on February 24. Following this, the stock rebounded as investors started buying the stock due to the low price.

    510(k) Application Filing

    As per Monday’s announcement, RMED submitted the 510(k) for its DABRA catheter with a braided over jacket and six-month shelf life. The application was filed for the catheter as a device for crossing chronic total occlusions in symptomatic infrainguinal lower extremity vascular disease patients. It also includes an intended use for ablating a channel in occlusive peripheral vascular disease.

    Source: RegDesk

    This marks a significant step achievement in the company’s flagship commercial DABRA catheter.

    The company manufactures the DABRA excimer laser and catheters in an ISO 13485 vertically integrated facility.

    RMED’s Financial Summary

    In Q3 2021, the company reported net revenue of $5000 from continuing operations and $0.5 million from discontinued operations.

    Furthermore, RMED had $7.4 million in loss from continued operations and $0.4 million from discontinued operations in the quarter.

  • Ra Medical Systems Inc. (RMED) stock Makes a Comeback After Hours. Any Reason?

    Ra Medical Systems Inc. (RMED) stock Makes a Comeback After Hours. Any Reason?

    On February 17, 2022, shares of Ra Medical Systems Inc. (RMED) made a comeback in the after-hours session. There is no new announcement or SEC filing from the company.

    In the previous trading session, the stock suffered a loss of 6.27% at its closing price of $0.39. The stock declined at an active volume of 4.3 million shares during the session. RMED saw a reversal in the after-hours session as it rebounded to reach $0.46 per share. The stock added a value of 17.95% or $0.07 in the after-hours on Thursday.

    Founded in 2002, Ra Medical Systems Inc. develops excimer lasers for dermatologic and cardiovascular diseases. Currently, its 26.33 million outstanding shares trade at a market capitalization of $6.88 million.

    RMED stock Movement

    On February 15, the company filed an amendment on an SC 13G form with the Securities Exchange Commission. The stock had been bullish since the SEC filing. Although the gains were mild, the stock remained in an uptrend for two days. It seems the stock suffered a loss due to a profit booking event from the recent gains on Thursday. Following this, RMED resumed its bullish momentum but with a much higher pace.

    A further explanation of the recent bullishness could be the Russia-Ukraine conflict. The stock market is generally down due to the ongoing conflict and increased problems between the countries. Even in situations like these, there are always a few penny stocks that remain bullish and hence attract investors. With the downtrend in the market, it seems investors found RMED as a good penny stock to make some profits.

    Latest Patent

    Recently, the company announced receiving its 10th U.S. patent from the United States Patent and Trademark Office on February 08, 2022. The patent was granted to RMED for a support catheter used with a small flexible liquid core catheter for laser ablation of blockages for restoring blood flow.

    The U.S. patent 11,241,519 B2 is titled Small Flexible Liquid Core Catheter for Laser Ablation in Body Lumens and Methods for Use. This patent further strengthens the company’s intellectual property portfolio for the full commercialization of the DABRA excimer laser system.

    RMED’s Financial Overview

    In Q3 2021, the company reported net revenues of $5000 from continuing operations and $0.5 million from discontinued operations.

    Moreover, the loss was $7.4 million from continuing operations and $0.4 million from discontinued operations in the quarter.

     

  • Ra Medical Systems, Inc. (RMED) gained in the Pre-market; here is why?

    Ra Medical Systems, Inc. (RMED) gained in the Pre-market; here is why?

    Ra Medical Systems, Inc. (RMED) gained in the pre-market after announcing its 10th patent. RMED values at $0.42, gaining more than 4% compared to yesterday’s closing price. The stock closed at $0.40 at the end of the last trading session. The stock volume traded in the last trading session was around 2.22 million shares. The current market cap of the company is around $6.66 million.

    Ra Medical Systems, Inc. (RMED) announced its 10th U.S. patent

    It was on February 8, 2022, when a new patent for an arterial plaque blockage laser ablation support catheter was issued to RMED. With its tenth U.S. patent, Ra Medical has created innovative liquid core ablation catheters.

    Laser Ablation in Body Lumens and Methods of Use with a Small Flexible Liquid Core Catheter is described in detail in the article. The DABRA ablation and support catheters have been tested in difficult-to-treat peripheral veins by medical experts at RMED.

    RMED CEO’s remarks on the patent

    Our DABRA liquid core ablation catheters can now be used in difficult anatomies, according to CEO Will McGuire. He also said that we are certain that this patent will speed up the commercialization of the DABRA excimer laser system.

    RMED lost more than 94% in the Trailing Twelve Months

    Ra Medical Systems, Inc. (RMED) lost more than 94% value in twelve months. The company is struggling to make significant revenue. Five years ago, the stock’s value was $455 per share, but it sells for peanuts at $0.42, losing more than 99% value. The revenue in the last reported quarter was a mere $5K.

    Conclusion

    Ra Medical Systems, Inc. (RMED) is not profitable for the past few years and is barely making any money. The new patent might seem like a savior, but the company needs to focus on rolling the treatment.

  • Market Movers: What changed for these 45 stocks while you were sleeping

    FuelCell Energy Inc. (FCEL) stock soared 7.34% to $4.02 in the pre-market trading. The most recent rating by JP Morgan, on October 08, 2020, is Overweight.

    Blink Charging Co. (NASDAQ: BLNK) shares are trading up 5.5% at $12.86 at the time of writing after the company introduction of its innovative Cable Management Solution for use with both new Blinks charging stations and retrofit installations of its IQ 200 charging stations. Blink’s 52-week range was noted as $1.25 to $14.58.

    Canaan Inc. (CAN) grew over 6.38% at $3.5 in pre-market trading today after the announced its third-quarter earnings results.

    Zomedica Pharmaceuticals Corp. (ZOM), a Drug Manufacturers – Specialty & Generic company, rose about 6.25% at $0.119 in pre-market trading Tuesday.

    American Resources Corporation (AREC) stock moved up 6.17 percent to $1.72 in the pre-market trading after the company announced that Mark Jensen, Chairman, and CEO of American Resources Corporation was chosen to attend the Proactive ONE2ONE Strategic Metals Supply Chain Investor Forum on Tuesday, November 10, 2020, at 1:00 PM ET.

    Li Auto Inc. (LI) gained over 6.78% at $37.96 in pre-market trading Tuesday 17 November 2020 after the company announced an upbeat Earnings result.

    Anworth Mortgage Asset Corporation (ANH) is up more than 5.42% at $2.14 in pre-market hours Tuesday 17 November 2020 after the announcement by the company that in accordance with the terms of Anworth’s 8.625% Series A Cumulative Preferred stock, the board of directors declared a Series A Preferred Stock dividend of $0.539063 per share for the fourth quarter of 2020. The stock had jumped over 11.54% to $2.03 in the last trading session.

    Before the trading started on 17 November 2020, Kandi Technologies Group Inc. (KNDI) is up 4.74% to reach $8.4 as the report arrives that it closed a registered direct offering of 9,404,392 units of its securities at a purchase price per Unit of $6.38, generating aggregate gross proceeds to the Company of approximately $60,000,000, before deducting fees to the placement agent and other estimated offering expenses payable by the Company. It has been trading in a 52-week range of $2.17 to $17.40.

    New Concept Energy Inc. (GBR) stock soared 16.48% to $2.12 in the pre-market trading following the announcement of the company’s Q3 2020, fiscal results.

    Vaxart Inc. (NASDAQ: VXRT) shares are trading up 7.36% at $5.98 at the time of writing. The company’s 52-week range was noted as $0.27 to $17.49 as the company said it is hosting a key opinion leader panel call for investors. Analysts have a consensus price target of $17.

    Platinum Group Metals Ltd. (PLG) grew over 3.54% at $2.05 in pre-market trading today.

    Muscle Maker Inc. (GRIL), a Restaurant company, rose about 2.94% at $2.1 in pre-market trading Tuesday after the company announced the launch of its online meal plan delivery service platform.

    Sasol Limited (SSL) stock moved up 3.73 percent to $7.51 in the pre-market trading after the company announced the beneficial operation of the Louisiana low-density polyethylene unit.

    Ocean Power Technologies Inc. (OPTT) gained over 2.23% at $1.83 in pre-market trading Tuesday 17 November 2020 after the company announced receipt of a DeepStar project award to study the deployment and operational requirements of utilizing OPT’s PB3 PowerBuoy to provide remotely controllable zero-carbon power for deepwater subsea oil production applications.

    Waitr Holdings Inc. (WTRH) is up more than 3.26% at $2.85 in pre-market hours Tuesday 17 November 2020 after the company earnings beat analysts’ expectations. The stock had jumped over 5.34% to $2.76 in the last trading session.

    Before the trading started on 17 November 2020, XPeng Inc. (XPEV) is up 6.33% to reach $46.89 after the company announced upbeat operating and financial results as a Public Company. It has been trading in a 52-week range of $17.11 to $51.27.

    Sequans Communications S.A. (SQNS) stock soared 15.84% to $5.34 in pre-market trading. The most recent rating by B. Riley FBR, on May 18, 2020, is a Buy.

    Live Oak Bancshares Inc. (NASDAQ: LOB) shares are trading up 3.51% at $46.89 at the time of writing. The company’s 52-week range was noted as $7.57 to $43.95. Analysts have a consensus price target of $42.

    Yunhong CTI Ltd. (CTIB) grew over 27.62% at $2.31 in pre-market trading today after the company announced production capacity expansion at its lake Barrington, Illinois facility to meet increased customer demand.
    .

    Neptune Wellness Solutions Inc. (NEPT), a Drug Manufacturers – Specialty & Generic company, rose about 15.71% at $2.21 in pre-market trading Tuesday after the firm received Over US$100 million in purchase orders.

    Gevo Inc. (GEVO) stock moved up 6.8 percent to $1.1 in the pre-market trading after the company posted Q3 results.

    So-Young International Inc. (SY) gained over 5.0% at $14.28 in pre-market trading Tuesday 17 November 2020 after the company said that it will report third-quarter 2020 financial results on November 25, 2020.

    Sequential Brands Group Inc. (SQBG) is up more than 41.84% at $10.0 in pre-market hours Tuesday 17 November 2020. The stock had jumped over 2.92% to $7.05 in the last trading session as the company announced its Q3, 2020 Earnings results.

    Before the trading started on 17 November 2020, MICT Inc. (MICT) is up 4.55% to reach $1.61. It has been trading in a 52-week range of $0.44 to $8.45.

    The Macerich Company (MAC) stock plunged -0.11% to $9.03 in the pre-market trading after the company’s announcement of its earnings results. The most recent rating by Morgan Stanley, on September 14, 2020, is an Underweight.

    Aphria Inc. (NASDAQ: APHA)c shares are trading down 0.0% at $5.8 at the time of writing after the company announced that its management will host a fireside chat discussion at the Jefferies Virtual London Healthcare Conference on Wednesday, November 18, 2020, at 9:05 a.m. ET. The company’s 52-week range was noted as $1.95 to $6.44.

    NIO Limited (NIO) grew over 3.23% at $47.05 in pre-market trading today as the company is set to announce its earnings results.

    BIO-key International Inc. (BKYI), a Security & Protection Services company, rose about 6.32% at $0.444 in pre-market trading Tuesday following the announcement of its quarterly earnings results.

    ObsEva SA (OBSV) stock moved up 6.64 percent to $2.25 in the pre-market trading as the company reported positive topline results of the PROLONG proof-of-concept trial of ebopiprant for treatment of preterm labor.

    Schrodinger Inc. (SDGR) gained over 5.29% at $61.9 in pre-market trading Tuesday 17 November 2020 as the company revealed third fiscal quarter results and business update.

    Lexicon Pharmaceuticals Inc. (LXRX) is up more than 51.16% at $1.95 in pre-market hours Tuesday 17 November 2020 after the company announced its participation in the Stifel 2020 Virtual Healthcare Conference on Wednesday, November 18, 2020. The stock had jumped over 1.57% to $1.29 in the last trading session.

    Before the trading started on 17 November 2020, JOYY Inc. (YY) is up 7.76% to reach $103.0 after the report that Baidu has acquired JOYY for $3.6 billion. It has been trading in a 52-week range of $41.33 to $104.17.

    Bristol-Myers Squibb Company (BMY) stock soared 2.82% to $66.32 in the pre-market trading after Bristol Myers Squibb offered a regulatory update on Lisocabtagene Maraleucel. The most recent rating by Societe Generale, on November 16, 2020, is a Buy.

    Phio Pharmaceuticals Corp. (NASDAQ: PHIO) shares are trading up 5.33% at $2.37 at the time of writing as the firm announced Q3 earnings results and business update. The company’s 52-week range was noted as $1.60 to $13.69. Analysts have a consensus price target of $4.

    PG&E Corporation (PCG) grew over 2.95% at $11.88 in pre-market trading today after the announcement made by the company that CEO Jeff Ramson will join a panel at the Virtual Fall Investor Summit taking place on November 16- 18, 2020.

    strong>Niu Technologies (NIU), an Auto Manufacturers company, rose about 4.52% at $34.47 in pre-market trading Tuesday.

    Avinger Inc. (AVGR) stock moved up 3.87 percent to $0.2789 in the pre-market trading after the company posted Q3 results.

    T-Mobile US Inc. (TMUS) gained over 3.23% at $132.8 in pre-market trading Tuesday 17 November 2020 after the report that Peter Osvaldik, executive vice president & chief financial officer, Neville Ray, president of technology, and Matt Staneff, executive vice president & chief marketing officer of T-Mobile US, Inc. (NASDAQ: TMUS), will present and provide a business update on Thursday, November 19, 2020, at 1:20 p.m. Eastern Time (ET) at the Morgan Stanley European Technology, Media & Telecom Conference.

    Tesla Inc. (TSLA) is up more than 12.45% at $458.9 in pre-market hours Tuesday 17 November 2020 after a report of the company joining the S&P 500. The stock had dropped over -0.10% to $408.09 in the last trading session.

    Before the trading started on 17 November 2020, CHF Solutions Inc. (CHFS) is up 2.31% to reach $6.2 as the company announced a 52% rise in Revenue in the earnings report. It has been trading in a 52-week range of $5.80 to $38.70.

    Aerie Pharmaceuticals Inc. (AERI) stock soared 3.94% to $13.46 in the pre-market trading after the company received positive CHMP opinion for roclanda in the European Union. The most recent rating by BofA Securities, on October 19, 2020, is an Underperform.

    Venus Concept Inc. (NASDAQ: VERO) shares are trading up 5.31% at $2.18 at the time of writing as the company revealed its Q3 results and business update. The company’s 52-week range was noted as $2.02 to $9.00. Analysts have a consensus price target of $6.

    Qudian Inc. (QD) grew over 2.6% at $1.58 in pre-market trading today.

    Celsion Corporation (CLSN), a Biotechnology company, rose about 3.77% at $0.55 in pre-market trading Tuesday as the company revealed its quarterly Earnings report.

    Tencent Music Entertainment Group (TME) stock moved up 2.98 percent to $16.58 in the pre-market trading.

    Net Element Inc. (NETE) is up more than 3.27% at $7.59 in pre-market hours Tuesday 17 November 2020 as the company reported its Q3 earnings results. The stock had dropped over -3.92% to $7.35 in the last trading session.